Neuropsychopharmacology is a multidisciplinary field that explores the effects of drugs on the brain and behavior, with the goal of understanding and treating neuropsychiatric disorders. It encompasses the study of the mechanisms of action of psychoactive substances, their effects on neurotransmitter systems, and their impact on cognitive, emotional, and behavioral processes. By elucidating the neurobiological basis of psychiatric disorders and the pharmacological mechanisms of psychoactive drugs, neuropsychopharmacology aims to develop novel treatments that target specific neural circuits and molecular pathways implicated in mental illness.
Research in neuropsychopharmacology spans a wide range of topics, including the neurochemistry of neurotransmitters such as dopamine, serotonin, and glutamate, the pharmacology of psychotropic medications, the neurobiology of addiction and substance abuse, and the development of novel pharmacological interventions for psychiatric disorders. Advances in neuroscience techniques, such as neuroimaging, electrophysiology, and molecular biology, have revolutionized our understanding of brain function and dysfunction and have led to the identification of new drug targets and treatment approaches. By integrating insights from basic science research with clinical observations, neuropsychopharmacologists strive to translate scientific discoveries into effective treatments that improve the lives of individuals with neuropsychiatric disorders.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States